Havlir DV - Search Results

1

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

Havlir DV, Dubé MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Kumar PN, White AC Jr, Witt MD, Nightingale SD, Sepkowitz KA, MacGregor RR, Cheeseman SH, Torriani FJ, Zelasky MT, Sattler FR, Bozzette SA. Havlir DV, et al. Clin Infect Dis. 1998 Dec;27(6):1369-75. doi: 10.1086/515018. Clin Infect Dis. 1998. PMID: 9868644 Clinical Trial.

2

A 32-year-old man with the acquired immunodeficiency syndrome and pneumococcal meningitis.

Havlir DV, Witt MD, Sande M. Havlir DV, et al. West J Med. 1987 May;146(5):618-9. West J Med. 1987. PMID: 3590766 Free PMC article. No abstract available.

3

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D, et al. Richman DD, et al. J Virol. 1994 Mar;68(3):1660-6. doi: 10.1128/JVI.68.3.1660-1666.1994. J Virol. 1994. PMID: 7509000 Free PMC article.

4

Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.

Cheeseman SH, Havlir D, McLaughlin MM, Greenough TC, Sullivan JL, Hall D, Hattox SE, Spector SA, Stein DS, Myers M, et al. Cheeseman SH, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Feb 1;8(2):141-51. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7530585 Clinical Trial.

5

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection.

Havlir D, Cheeseman SH, McLaughlin M, Murphy R, Erice A, Spector SA, Greenough TC, Sullivan JL, Hall D, Myers M, et al. Havlir D, et al. J Infect Dis. 1995 Mar;171(3):537-45. doi: 10.1093/infdis/171.3.537. J Infect Dis. 1995. PMID: 7533197 Clinical Trial.

6

A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208.

Havlir D, McLaughlin MM, Richman DD. Havlir D, et al. J Infect Dis. 1995 Nov;172(5):1379-83. doi: 10.1093/infdis/172.5.1379. J Infect Dis. 1995. PMID: 7594683 Clinical Trial.

7

Mycobacterium avium complex: advances in therapy.

Havlir DV. Havlir DV. Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):915-24. doi: 10.1007/BF02111492. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7698117 Review.

8

Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia.

Torriani FJ, McCutchan JA, Bozzette SA, Grafe MR, Havlir DV. Torriani FJ, et al. Among authors: havlir dv. J Infect Dis. 1994 Dec;170(6):1601-5. doi: 10.1093/infdis/170.6.1601. J Infect Dis. 1994. PMID: 7996004

9

The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.

Kemper CA, Havlir D, Haghighat D, Dubé M, Bartok AE, Sison JP, Yao Y, Yangco B, Leedom JM, Tilles JG, et al. Kemper CA, et al. J Infect Dis. 1994 Jul;170(1):157-64. doi: 10.1093/infdis/170.1.157. J Infect Dis. 1994. PMID: 8014492 Clinical Trial.

10

Transient bacteremia due to Mycobacterium avium complex in patients with AIDS.

Kemper CA, Havlir D, Bartok AE, Kane C, Camp B, Lane N, Deresinski SC. Kemper CA, et al. J Infect Dis. 1994 Aug;170(2):488-93. doi: 10.1093/infdis/170.2.488. J Infect Dis. 1994. PMID: 8035044 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page